Logo image of ZX6.DE

DSM-FIRMENICH AG (ZX6.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:ZX6 - CH1216478797 - Common Stock

68.28 EUR
+2.26 (+3.42%)
Last: 1/15/2026, 7:00:00 PM
Fundamental Rating

3

ZX6 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. The financial health of ZX6 is average, but there are quite some concerns on its profitability. ZX6 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ZX6 had positive earnings in the past year.
  • In the past year ZX6 had a positive cash flow from operations.
ZX6.DE Yearly Net Income VS EBIT VS OCF VS FCFZX6.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of ZX6 (0.77%) is comparable to the rest of the industry.
  • ZX6 has a Return On Equity of 1.17%. This is comparable to the rest of the industry: ZX6 outperforms 47.83% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.27%, ZX6 is doing worse than 63.77% of the companies in the same industry.
Industry RankSector Rank
ROA 0.77%
ROE 1.17%
ROIC 1.27%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZX6.DE Yearly ROA, ROE, ROICZX6.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • With a Profit Margin value of 1.95%, ZX6 perfoms like the industry average, outperforming 55.07% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ZX6 has declined.
  • ZX6 has a Operating Margin (4.38%) which is in line with its industry peers.
  • ZX6's Operating Margin has declined in the last couple of years.
  • ZX6 has a Gross Margin (33.17%) which is in line with its industry peers.
  • ZX6's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.38%
PM (TTM) 1.95%
GM 33.17%
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
ZX6.DE Yearly Profit, Operating, Gross MarginsZX6.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZX6 is destroying value.
  • The number of shares outstanding for ZX6 remains at a similar level compared to 1 year ago.
  • ZX6 has a worse debt/assets ratio than last year.
ZX6.DE Yearly Shares OutstandingZX6.DE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M 250M
ZX6.DE Yearly Total Debt VS Total AssetsZX6.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.13 indicates that ZX6 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ZX6's Altman-Z score of 2.13 is in line compared to the rest of the industry. ZX6 outperforms 43.48% of its industry peers.
  • The Debt to FCF ratio of ZX6 is 7.12, which is on the high side as it means it would take ZX6, 7.12 years of fcf income to pay off all of its debts.
  • ZX6 has a Debt to FCF ratio of 7.12. This is in the better half of the industry: ZX6 outperforms 65.22% of its industry peers.
  • A Debt/Equity ratio of 0.24 indicates that ZX6 is not too dependend on debt financing.
  • The Debt to Equity ratio of ZX6 (0.24) is better than 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Altman-Z 2.13
ROIC/WACC0.31
WACC4.07%
ZX6.DE Yearly LT Debt VS Equity VS FCFZX6.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 2.69 indicates that ZX6 has no problem at all paying its short term obligations.
  • The Current ratio of ZX6 (2.69) is better than 81.16% of its industry peers.
  • ZX6 has a Quick Ratio of 1.74. This is a normal value and indicates that ZX6 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ZX6 (1.74) is better than 81.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 1.74
ZX6.DE Yearly Current Assets VS Current LiabilitesZX6.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

  • The earnings per share for ZX6 have decreased strongly by -89.70% in the last year.
  • The earnings per share for ZX6 have been decreasing by -45.42% on average. This is quite bad
  • ZX6 shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.44%.
  • ZX6 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.80% yearly.
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 16.52% on average over the next years. This is quite good.
  • ZX6 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.11% yearly.
EPS Next Y17.14%
EPS Next 2Y8.89%
EPS Next 3Y11.09%
EPS Next 5Y16.52%
Revenue Next Year-1.29%
Revenue Next 2Y-0.44%
Revenue Next 3Y1.27%
Revenue Next 5Y3.11%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ZX6.DE Yearly Revenue VS EstimatesZX6.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
ZX6.DE Yearly EPS VS EstimatesZX6.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 72.64 indicates a quite expensive valuation of ZX6.
  • Based on the Price/Earnings ratio, ZX6 is valued a bit more expensive than the industry average as 63.77% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 27.54, ZX6 is valued quite expensively.
  • ZX6 is valuated rather expensively with a Price/Forward Earnings ratio of 17.72.
  • ZX6's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ZX6 is cheaper than 62.32% of the companies in the same industry.
  • ZX6's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.31.
Industry RankSector Rank
PE 72.64
Fwd PE 17.72
ZX6.DE Price Earnings VS Forward Price EarningsZX6.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZX6 is on the same level as its industry peers.
  • ZX6's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ZX6 is cheaper than 69.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.81
EV/EBITDA 10.87
ZX6.DE Per share dataZX6.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZX6 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.24
PEG (5Y)N/A
EPS Next 2Y8.89%
EPS Next 3Y11.09%

3

5. Dividend

5.1 Amount

  • ZX6 has a Yearly Dividend Yield of 3.75%.
  • ZX6's Dividend Yield is a higher than the industry average which is at 2.45.
  • Compared to an average S&P500 Dividend Yield of 1.92, ZX6 pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.75%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • ZX6 pays out 286.40% of its income as dividend. This is not a sustainable payout ratio.
DP286.4%
EPS Next 2Y8.89%
EPS Next 3Y11.09%
ZX6.DE Yearly Income VS Free CF VS DividendZX6.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 500M 1B 1.5B 2B
ZX6.DE Dividend Payout.ZX6.DE Dividend Payout, showing the Payout Ratio.ZX6.DE Dividend Payout.PayoutRetained Earnings

DSM-FIRMENICH AG

FRA:ZX6 (1/15/2026, 7:00:00 PM)

68.28

+2.26 (+3.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-30
Earnings (Next)02-12
Inst Owners32.36%
Inst Owner ChangeN/A
Ins Owners9.06%
Ins Owner ChangeN/A
Market Cap18.14B
Revenue(TTM)12.80B
Net Income(TTM)250.00M
Analysts79.33
Price Target103.84 (52.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.75%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP286.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.41%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.8%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 72.64
Fwd PE 17.72
P/S 1.42
P/FCF 23.81
P/OCF 11.41
P/B 0.85
P/tB 3.79
EV/EBITDA 10.87
EPS(TTM)0.94
EY1.38%
EPS(NY)3.85
Fwd EY5.64%
FCF(TTM)2.87
FCFY4.2%
OCF(TTM)5.98
OCFY8.76%
SpS48.17
BVpS80.37
TBVpS18.03
PEG (NY)4.24
PEG (5Y)N/A
Graham Number41.23
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.17%
ROCE 1.94%
ROIC 1.27%
ROICexc 1.41%
ROICexgc 3.87%
OM 4.38%
PM (TTM) 1.95%
GM 33.17%
FCFM 5.95%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
F-Score7
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Debt/EBITDA 2.72
Cap/Depr 61.7%
Cap/Sales 6.47%
Interest Coverage 7.37
Cash Conversion 83.6%
Profit Quality 304.8%
Current Ratio 2.69
Quick Ratio 1.74
Altman-Z 2.13
F-Score7
WACC4.07%
ROIC/WACC0.31
Cap/Depr(3y)68.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.69%
Cap/Sales(5y)N/A
Profit Quality(3y)150.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y17.14%
EPS Next 2Y8.89%
EPS Next 3Y11.09%
EPS Next 5Y16.52%
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-1.29%
Revenue Next 2Y-0.44%
Revenue Next 3Y1.27%
Revenue Next 5Y3.11%
EBIT growth 1Y226.7%
EBIT growth 3Y-11.79%
EBIT growth 5YN/A
EBIT Next Year129.44%
EBIT Next 3Y34.02%
EBIT Next 5Y24.44%
FCF growth 1Y160.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.8%
OCF growth 3YN/A
OCF growth 5YN/A

DSM-FIRMENICH AG / ZX6.DE FAQ

What is the ChartMill fundamental rating of DSM-FIRMENICH AG (ZX6.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ZX6.DE.


Can you provide the valuation status for DSM-FIRMENICH AG?

ChartMill assigns a valuation rating of 2 / 10 to DSM-FIRMENICH AG (ZX6.DE). This can be considered as Overvalued.


How profitable is DSM-FIRMENICH AG (ZX6.DE) stock?

DSM-FIRMENICH AG (ZX6.DE) has a profitability rating of 2 / 10.


What is the valuation of DSM-FIRMENICH AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DSM-FIRMENICH AG (ZX6.DE) is 72.64 and the Price/Book (PB) ratio is 0.85.


What is the financial health of DSM-FIRMENICH AG (ZX6.DE) stock?

The financial health rating of DSM-FIRMENICH AG (ZX6.DE) is 5 / 10.